Econugenics PectaSol® Modified Citrus Pectin, Lime Infusion, 19.44 oz (1.21 lb)
UPC: 892985000188
Econugenics PectaSol Modified Citrus Pectin is a powdered supplement designed to support cellular health, detoxification, and immune function. It features PectaSol-C® Modified Citrus Pectin, a patented ingredient derived from the pith of citrus fruit peels like lemons, limes, and oranges, which is processed to a smaller molecular size for absorption. The manufacturer states this form is backed by over 100 peer-reviewed studies and is the original clinically proven modified citrus pectin.
This Lime Infusion variant includes natural lime flavor and stevia leaf extract for taste, and it is also available in Unflavored and Berry-Infusion options. The product is produced under Good Manufacturing Practices (GMP) and is certified gluten-free, non-GMO, and vegan. According to the manufacturer, it should be taken on an empty stomach for optimal absorption, with a typical serving providing 5 grams of the active ingredient.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Total Carbohydrates | 4 g | 1%** |
| Dietary Fiber | 3 g | 11% |
| Sodium | 180 mg | 7% |
| Potassium | 420 mg | 9% |
| PectaSol-C® Modified Citrus Pectin | 5 g | † |
| † Daily Value not established | ||
Other Ingredients
Citric acid, natural lime flavor (lime oil, lime juice powder, citric acid), stevia leaf extract.
Certifications & Claims
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
As a dietary supplement, for maximum support, take 15 grams MCP per day (3 scoops) in 2-3 divided doses, mixed with water, on an empty stomach. For maintenance support, take 1 scoop per day, mixed with liquid, on an empty stomach, or as recommended by your healthcare practitioner.
Warning
Reproductive Harm - Prop 65.
Product Info
- Brand
- Econugenics
- UPC
- 892985000188
- Package Qty
- 1.21 lb
- Dimensions
- 6.4 x 3.7 x 3.7 in
- Shipping Weight
- 1.4 lb
- First Available
- 10/2023





